Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma

Mahdi, Haider

79
Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma

Sunday, March 29, 2015: 3:05 PM

Salon C-D (Hilton Chicago)

H. Mahdi¹, R. DeBernardo¹, M. Elshaikh², A. R. Munkarah², D. Isrow², S. Singh³, S. E. Waggoner³, R. Ali⁴, J. Harding⁵, R. T. Morris⁶ and M. Moslemi-Kebria¹
¹Cleveland Clinic, Cleveland, OH, ²Henry Ford Health System, Detroit, MI, ³University Hospitals Case Medical Center, Cleveland, OH, ⁴Wayne State University, Detroit, MI, ⁵Case Western Reserve Univesity, Cleveland, OH, ⁶Wayne State University School of Medicine, Detroit, MI

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

79
Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma

79 Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma

79
Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma